Abstract
Background Published literature indicates racial/ethnic minorities are underrepresented in clinical trials when compared to white/non-Hispanics. Enrollment of diverse populations is important because minorities have disproportionately higher rates of HIV infection. This analysis evaluates the enrollment process for minorities compared to whites at the Vaccine Research Center (VRC) Clinical Trials Core (CTC) among healthy HIV-uninfected volunteer into HIV vaccine studies in metropolitan Washington, DC.
Highlights
B Graham and JM LedgerwoodAddress: Vaccine Research Center/NIAID/NIH, Bethesda, MD, USA * Corresponding author from AIDS Vaccine 2009 Paris, France. 19-22 October 2009
Published literature indicates racial/ethnic minorities are underrepresented in clinical trials when compared to white/non-Hispanics
This analysis evaluates the enrollment process for minorities compared to whites at the Vaccine Research Center (VRC) Clinical Trials Core (CTC) among healthy HIV-uninfected volunteer into HIV vaccine studies in metropolitan Washington, DC
Summary
Address: Vaccine Research Center/NIAID/NIH, Bethesda, MD, USA * Corresponding author from AIDS Vaccine 2009 Paris, France. 19-22 October 2009. Address: Vaccine Research Center/NIAID/NIH, Bethesda, MD, USA * Corresponding author from AIDS Vaccine 2009 Paris, France. Published: 22 October 2009 Retrovirology 2009, 6(Suppl 3):P406 doi:10.1186/1742-4690-6-S3-P406. AIDS Vaccine 2009 Anna Laura Ross Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
